Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
58M
-
Shares change
-
+3.58M
-
Total reported value, excl. options
-
$554M
-
Value change
-
+$32.3M
-
Put/Call ratio
-
3.77
-
Number of buys
-
56
-
Number of sells
-
-47
-
Price
-
$9.56
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2022
132 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q1 2022.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (13.6M shares), Madison Avenue Partners, LP (7.27M shares), VANGUARD GROUP INC (6.95M shares), Weiss Asset Management LP (5.41M shares), ORBIMED ADVISORS LLC (3.25M shares), FMR LLC (2.69M shares), STATE STREET CORP (1.54M shares), Newtyn Management, LLC (1.38M shares), Woodline Partners LP (1.33M shares), and D. E. Shaw & Co., Inc. (1.24M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.